Diagnoses Disease, Lung Tumor
Conditions
Keywords
guide sheath, bronchoscopic biopsy
Brief summary
Whether using a guide sheath can increase the diagnostic yield rate after the lesion is located by radial endobronchial ultrasound
Detailed description
For lung nodules, there are several ways to acquire tissue for pathology study, including computed tomography (CT)-guided core needle biopsy, radial probe endobronchial ultrasound (rEBUS)-guided transbronchial lung biopsy (TBLB), convex probe EBUS transbronchial needle aspiration (TBNA), and echo-guided core needle biopsy. rEBUS-guided TBLB has relatively low limitation of lesion position, comparing to echo-guided core needle biopsy and EBUS-TBNA, and doesn't need to deal with the risk of radiation exposure.1 For peripheral pulmonary lesions (PPL), it has good yield rate and the operation is easy.2 However, when bleeding occurs, the procedure time is prolonged for hemostasis. Nonetheless, using a guide sheath can help with the problem. According to the literatures, biopsy yield rates vary but on average it is higher with a guide sheath (62\ 90% vs. 41\ 73%), while the complication rates are about the same (1.3\ 4.4% 1.5\ 5.0%). The investigators would like to know whether the diagnostic rate is higher with a guide sheath and so do the procedure time and the complication rate. Whether the lesion character affect the yield rate will also be studied.
Interventions
After the lesion was found by rEBUS, insert the rEBUS into a guide sheath and re-locate the lesion. Fix the guide sheath at that position and perform transbronchial biopsy and brushing through the guide sheath.
After the lesion was found by rEBUS, mark the location and depth. Insert the biopsy forceps and cytology brush to the marked depth of that bronchiole to perform biopsy and brushing.
Sponsors
Study design
Eligibility
Inclusion criteria
Age ≥ 20 years old. Radiographic evidence of peripheral pulmonary lesions. The lesion can be located by radial probe EBUS.
Exclusion criteria
B1 bronchus. Thrombocytopenia with platelet count \< 100K. Coagulopathy with INR \> 1.3. High oxygen demand (O2 mask \> 28%, 5L). Currently using anti-platelet drug or anti-coagulant.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The diagnostic yield rate i. Brushing cytology ii. Biopsy | 2 years | The diagnostic yield rate of transbronchial biopsy and brushing cytology by using guide sheath |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Procedure duration | 1 year | The procedure time of using a guide sheath |
| Complication rate (pneumothorax, hemoptysis) | 1 year | The complication rate of using a guide sheath |
Countries
Taiwan